Avigen Reports Second Quarter 2009 Financial Results
10 août 2009 12h59 HE
|
Avigen, Inc.
ALAMEDA, Calif., Aug. 10, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its second quarter ended June 30, 2009. At June 30,...
Avigen Granted AV411 Patent for Neuropathic Pain
20 mai 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., May 20, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, announced today that it has been granted United States Patent No. 7,534,806, entitled "Method...
Avigen Reports First Quarter 2009 Financial Results
11 mai 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., May 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN) a biopharmaceutical company, today reported financial results for its first quarter ended March 31, 2009. At March 31,...
Avigen's Stockholders Deny BVF's Bid to Remove Board of Directors in Proxy Fight
31 mars 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that based on the final tabulation of votes reported by the independent...
Avigen Board Discontinues Strategic Merger Discussions to Develop a Plan for Liquidation
26 mars 2009 09h21 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 26, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors has discontinued its strategic merger...
Leading Independent Advisory Service Urges Avigen Stockholders to Reject BVF's Proposal
18 mars 2009 14h40 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 18, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that its Board of Directors issued the following comments in a letter to...
Avigen's Board Urges Stockholders to Reject BVF's Proposal
11 mars 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., March 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today announced that it has scheduled a Special Meeting of Stockholders as requested by...
Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction
25 févr. 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that two preclinical reports with glial attenuator AV411 (ibudilast) support...
Avigen Reports 2008 Financial Results and Updates Progress On Strategic Review
11 févr. 2009 08h00 HE
|
Avigen, Inc.
ALAMEDA, Calif., Feb. 11, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, today reported financial results for its fourth quarter and year ended December 31, 2008. At...
Avigen Board Rejects BVF Offer as Inadequate
06 févr. 2009 08h00 HE
|
Avigen, Inc.
Recommends Stockholders Not Tender Shares
Company Reviewing Strategic Alternatives
ALAMEDA, Calif., Feb. 6, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a...